POLATOM and DSD Pharma strengthen their Partnership –Expanding to Germany

Jobsuche (1)

National Centre for Nuclear Research Radioisotope Centre POLATOM, – 22.01.2025 –

POLATOM, a leading manufacturer in the field of radiopharmaceuticals, and DSD Pharma, an established radiopharmaceutical distribution company announce the expansion of their successful partnership.

Effective immediately, DSD Pharma as official distributor of POLATOM in Austria will serve now the (I-131) radiopharmaceuticals also in Germany, namely Iodopol® (I-131) – therapeutic capsules with Marketing Authorization granted, beside Sodium iodide Na131I – diagnostic capsules as well as Iodine (I-131) – injection as non-registered products with import permit. These products are employed in the diagnosis and treatment of thyroid disorders, including thyroid cancer which affect a substantial portion of the population in Germany. Furthermore, MIBG-131I is a diagnostic and therapeutic injection solution employed in cancer treatment in treating disseminated, malignant, metastatic lesions, such as pheochromocytoma, paraganglioma, neuroblastoma, neuroendocrine tumors of gestroenteropancreatic tract, and sometimes medullary thyroid carcinoma.

This collaboration will enable the introduction of trusted products to the German market and improve patient care.

Statement by Piotr Czajka, Commercial Director of POLATOM: “We are excited to extend our long-standing partnership with DSD Pharma to the German market. DSD Pharma has established itself as a reliable partner in the distribution of cutting-edge healthcare solutions. With their strong network and extensive expertise, we are confident that together we can optimize the availability of our iodine radiopharmaceuticals in Germany and improve patient access to innovative diagnostic and treatment options.”

Statement by Susanne Dorudi, CEO of DSD Pharma: “The expanded collaboration with POLATOM marks a significant milestone for DSD Pharma. As an emerging player in radiopharmaceutical distribution, we recognize the immense potential in extending our reach into the iodine radiopharmaceutical market within Germany. Through this partnership, we aim to leverage our extensive experience in drug distribution alongside POLATOM’s cutting-edge products, ensuring enhanced patient care and contributing to the advancement of healthcare in the region.”

About POLATOM

POLATOM is a Polish producer and distributor of isotope preparations used in medicine, science, industry and environmental protection. It also conducts research and development works. They are of an application nature and concern radiopharmacy, chemistry and nuclear technology as well as such scientific disciplines as radiochemistry, biochemistry, and immunology. The result of the research is the development of their own technologies, implemented by NCBJ RC POLATOM.

 

About DSD Pharma
DSD Pharma is a renowned privately hold distribution company located in Austria, next to Vienna. DSD Pharma collaborates with both national and international suppliers and manufacturers, ensuring a diverse and comprehensive product portfolio. In addition to diagnostic solutions, DSD Pharma offers a wide range of therapeutics, medical devices, medical-technical equipment, as well as specialized tools for radiopharmacy and hot rooms.